RCUS · Healthcare · $3.2B
$25.83+0.70%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“매출은 전 분기 1,700만 달러에서 4,100만 달러로 크게 반등했고, 최근 네 분기 흐름도 2,600만→3,300만→1,700만→4,100만”
In the company's words · 2026 2분기 earnings call